We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFIC
1501
DELISTED
Flushing Financial
FFIC
| $1.86M | ﹤0.01% |
+147,268
| New | +$2.07M |
|
1502
Codexis
CDXS
$158M
| $1.86M | ﹤0.01% |
531,778
-52,211
| -9% | -$164K |
|
1503
Ring Energy
REI
$339M
| $1.85M | ﹤0.01% |
945,467
-79,840
| -8% | -$119K |
|
1504
TriplePoint Venture Growth BDC
TPVG
$211M
| $1.84M | ﹤0.01% |
194,171
-8,489
| -4% | -$90K |
|
1505
US Physical Therapy
USPH
$1.22B
| $1.84M | ﹤0.01% |
16,299
-25,105
| -61% | -$2.51M |
|
1506
Root
ROOT
$798M
| $1.84M | ﹤0.01% |
30,094
-32,193
| -52% | -$758K |
|
|
DEA
1507
Easterly Government Properties
DEA
$1.18B
| $1.83M | ﹤0.01% |
+63,613
| New | +$1.93M |
|
1508
Tennant Co
TNC
$1.26B
| $1.83M | ﹤0.01% |
15,024
-77,268
| -84% | -$7.89M |
|
1509
Ameresco
AMRC
$1.36B
| $1.83M | ﹤0.01% |
75,699
+55,970
| +284% | +$1.25M |
|
1510
ManpowerGroup
MAN
$2.63B
| $1.82M | ﹤0.01% |
+23,486
| New | +$1.75M |
|
1511
Forrester Research
FORR
$224M
| $1.82M | ﹤0.01% |
84,483
+37,377
| +79% | +$848K |
|
1512
Western Union
WU
$2.21B
| $1.82M | ﹤0.01% |
130,000
-367,274
| -74% | -$4.73M |
|
1513
Omega Healthcare
OHI
$14.7B
| $1.82M | ﹤0.01% |
+57,368
| New | +$1.74M |
|
|
BZUN
1514
Baozun
BZUN
$172M
| $1.82M | ﹤0.01% |
789,546
+107,246
| +16% | +$257K |
|
1515
Black Diamond Therapeutics
BDTX
$112M
| $1.82M | ﹤0.01% |
358,064
-9,229
| -3% | -$37.2K |
|
1516
Brink's
BCO
$4.62B
| $1.81M | ﹤0.01% |
19,613
+13,813
| +238% | +$1.15M |
|
|
TMHC
1517
DELISTED
Taylor Morrison
TMHC
| $1.81M | ﹤0.01% |
29,100
-5,038
| -15% | -$278K |
|
|
EWCZ
1518
DELISTED
European Wax Center
EWCZ
| $1.8M | ﹤0.01% |
138,840
-11,478
| -8% | -$164K |
|
|
AAN
1519
DELISTED
The Aaron's Company Inc
AAN
| $1.8M | ﹤0.01% |
240,162
-32,544
| -12% | -$304K |
|
1520
Dollar General
DG
$27.9B
| $1.8M | ﹤0.01% |
11,505
-116,609
| -91% | -$16.6M |
|
1521
EPAM Systems
EPAM
$5.03B
| $1.8M | ﹤0.01% |
6,500
| – | – |
|
1522
Aurora
AUR
$13.8B
| $1.79M | ﹤0.01% |
633,524
-1,325,720
| -68% | -$3.8M |
|
|
EXK
1523
Endeavour Silver
EXK
$2.83B
| $1.79M | ﹤0.01% |
741,178
-318,529
| -30% | -$567K |
|
1524
Qualys
QLYS
$6.35B
| $1.79M | ﹤0.01% |
10,697
-57,360
| -84% | -$10.1M |
|
1525
TTEC Holdings
TTEC
$124M
| $1.78M | ﹤0.01% |
171,748
+176
| +0.1% | +$2.95K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.